TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...

About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment ... on the success of the Organ Care System or OCS; our ability to expand ...

About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment ... on the success of the Organ Care System or OCS; our ability to expand ...

ANDOVER, Mass., Jan. 13, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...

In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

If you are a TransMedics investor and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003. On January ...

Shares of TransMedics Group (NASDAQ ... utilization of donor organs for transplants using the company's Organ Care System (OCS). Clinical outcomes were also much better with OCS.

Sustainalytics’ controversies research identifies companies involved in incidents and events that may negatively affect stakeholders, the environment or the company’s operations. Controversies are ...

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and widespread off-label misuse of its Organ Care System (OCS). In response to ...